Interlaminar Device Market Share

North American Market Statistics

The interlaminar device market in North America is predicted to account for the largest share of 38 % by the end of 2036. The market growth in the region is impelled by the rising adoption of interlaminar devices in the region. Countries such as the US, Mexico, and Canada are reported to have rising cases of spinal cord injuries resulting from road traffic accidents, falls, or rising aging populations. For instance, in the U.S., 21.5% of adults were found to include sports and exercise in their daily routines in 2021. Further, this is most likely to rise the demand for the interlaminar device in the area as it is used to stabilize the spine and protect it from any severe damage.

European Market Forecast

The European interlaminar device market is estimated to be the second largest with a share of 26%, during the forecast timeframe. The European market is poised to observe a dominant market for interlaminar devices as a result of better healthcare infrastructure, greater awareness, an improved reimbursement picture, and expanding insurance coverage.

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of interlaminar device is assessed at USD 624.99 Million.

The interlaminar device market size was over USD 592.46 Million in 2023 and is expected to reach USD 1.27 Billion by the end of 2036, witnessing around 6.1% CAGR during the forecast period i.e., between 2024-2036. Growing Cases of Sports Injuries and the growing advancements in spine surgery technologies across the globe are the major factors driving the market growth.

North America is predicted to account for the largest share of 38% by 2036, impelled by rising adoption of interlaminar devices in the region.

NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC

Interlaminar Device Market Share